This virtual webinar series titled “HF21 series / 21 episodes / 21 minutes: CHFS Perspective and Case-Based Approach on the 2021 CHFS/CCS HF Guidelines” is now available on demand. Canadian Experts shared their practical tips around the implementation of CCS/CHFS guidelines into the management of your patients with heart failure.

Faculty

• Grace Chua, MD, FRCPC, FACC
• Lisa Mielniczuk, MD, FRCPC
• Graham Wong, MD, MPH, FRCPC, FACC, FCCS, FAHA
• Shelley Zieroth, MD, FCCS, FHFSA (Hon), FESC, FACC, FHFA, FRCPC
• Ryan Davey, MD, FRCPC, FACC
• Sabe De, MD, FRCPC, FASE
• Jonathan Howlett, MD, FRCPC, FCCS, FACC, FHFS (Hon)

Learning Objectives:

• Apply recommendations from the 2021 CCS/CHFS Guidelines Update into clinical practice. (Medical Expert, Professional)
• Assess the importance of implementing 4 key therapeutic drug classes as standard therapy for most patients with HFrEF. (Medical Expert, Professional)
• Evaluate which patients will require additional key therapies and non-pharmacological interventions based on individual clinical characteristics. (Medical Expert, Professional)